Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Nordlund JJ, Kirkwood JM, Forget BM et al (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–696PubMedCrossRef
2.
Gogas H, Ioannovich J, Dafni U et al (2006) Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354(7):709–718PubMedCrossRef
3.
Uchi H, Stan R, Turk MJ et al (2006) Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo. Adv Immunol 90:215–241PubMedCrossRef
4.
Ramirez-Montagut T, Turk MJ, Wolchok JD et al (2003) Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene 22(20):3180–3187PubMedCrossRef
5.
Weitzen R, Pfeffer R, Mandel M (2005) Benign lesions in cancer patients: case 3. Vitiligo after radiotherapy for breast cancer in a woman with depigmentation disorder. J Clin Oncol 23(3):644PubMedCrossRef
6.
Koo SW, Suh CO, Hann SK (1996) Vitiligo following radiotherapy for carcinoma of the breast. Br J Dermatol 135(5):852–853PubMedCrossRef
7.
Levine EL, Ribeiro GG (1994) Vitiligo and radiotherapy: the Koebner phenomenon demonstrated in patients with vitiligo undergoing radiotherapy for carcinoma of the breast. Clin Oncol (R Coll Radiol) 6(2):133–134
8.
9.
Schmid-Wendtner MH, Wendtner CM, Volkenandt M et al (2001) Clinical picture: leopard-like vitiligo with capecitabine. Lancet 358(9293):1575PubMedCrossRef
Metadata
Title
Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer
Authors
Maithili V. Rao
Michelle Shayne
Publication date
01-09-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0074-6

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue

Epidemiology

Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users

Clinical Trial

Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow

Brief Report

Lobular involution: localized phenomenon or field effect?

Preclinical Study

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo

Letter to the Editor

UGT2B7 is not expressed in normal breast

Clinical Trial

Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits